333 related articles for article (PubMed ID: 18948358)
1. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial.
Schmidt H; Kern W; Giese R; Hallschmid M; Enders A
J Med Genet; 2009 Apr; 46(4):217-22. PubMed ID: 18948358
[TBL] [Abstract][Full Text] [Related]
2. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
[TBL] [Abstract][Full Text] [Related]
3. Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial.
Zwanenburg RJ; Bocca G; Ruiter SA; Dillingh JH; Flapper BC; van den Heuvel ER; van Ravenswaaij-Arts CM
Eur J Hum Genet; 2016 Dec; 24(12):1696-1701. PubMed ID: 27577546
[TBL] [Abstract][Full Text] [Related]
4. 22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay.
Cusmano-Ozog K; Manning MA; Hoyme HE
Am J Med Genet C Semin Med Genet; 2007 Nov; 145C(4):393-8. PubMed ID: 17926345
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.
Koolen DA; Reardon W; Rosser EM; Lacombe D; Hurst JA; Law CJ; Bongers EM; van Ravenswaaij-Arts CM; Leisink MA; van Kessel AG; Veltman JA; de Vries BB
Eur J Hum Genet; 2005 Sep; 13(9):1019-24. PubMed ID: 15986041
[TBL] [Abstract][Full Text] [Related]
6. Neurobehavioral profile and brain imaging study of the 22q13.3 deletion syndrome in childhood.
Philippe A; Boddaert N; Vaivre-Douret L; Robel L; Danon-Boileau L; Malan V; de Blois MC; Heron D; Colleaux L; Golse B; Zilbovicius M; Munnich A
Pediatrics; 2008 Aug; 122(2):e376-82. PubMed ID: 18625665
[TBL] [Abstract][Full Text] [Related]
7. [The Phelan-McDermid syndrome (22q13 microdeletion) - case report].
Slezak R; Laczmańska I
Med Wieku Rozwoj; 2011; 15(1):96-100. PubMed ID: 21786519
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3.
Delahaye A; Toutain A; Aboura A; Dupont C; Tabet AC; Benzacken B; Elion J; Verloes A; Pipiras E; Drunat S
Eur J Med Genet; 2009; 52(5):328-32. PubMed ID: 19454329
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion.
Gerdes M; Solot C; Wang PP; Moss E; LaRossa D; Randall P; Goldmuntz E; Clark BJ; Driscoll DA; Jawad A; Emanuel BS; McDonald-McGinn DM; Batshaw ML; Zackai EH
Am J Med Genet; 1999 Jul; 85(2):127-33. PubMed ID: 10406665
[TBL] [Abstract][Full Text] [Related]
10. The deletion 22q13 syndrome: a new case.
Karaman A; Aydin H; Geçkinli B; Göksu K
Genet Couns; 2015; 26(1):53-60. PubMed ID: 26043508
[TBL] [Abstract][Full Text] [Related]
11. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial disease in 22q13 duplication syndrome.
Frye RE
J Child Neurol; 2012 Jul; 27(7):942-9. PubMed ID: 22378673
[TBL] [Abstract][Full Text] [Related]
13. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome.
Sarasua SM; Dwivedi A; Boccuto L; Chen CF; Sharp JL; Rollins JD; Collins JS; Rogers RC; Phelan K; DuPont BR
Genet Med; 2014 Apr; 16(4):318-28. PubMed ID: 24136618
[TBL] [Abstract][Full Text] [Related]
14. Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development.
Wilson HL; Crolla JA; Walker D; Artifoni L; Dallapiccola B; Takano T; Vasudevan P; Huang S; Maloney V; Yobb T; Quarrell O; McDermid HE
Eur J Hum Genet; 2008 Nov; 16(11):1301-10. PubMed ID: 18523453
[TBL] [Abstract][Full Text] [Related]
15. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence.
Swillen A; Devriendt K; Legius E; Prinzie P; Vogels A; Ghesquière P; Fryns JP
Genet Couns; 1999; 10(1):79-88. PubMed ID: 10191433
[TBL] [Abstract][Full Text] [Related]
16. Deletion syndrome 22q13: what the dentist should know to manage children with Phelan-McDermid syndrome effectively.
Ivanoff C; Ivanoff AE
J Tenn Dent Assoc; 2014; 94(1):15-8; quiz 19-20. PubMed ID: 25241497
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal deletion unmasking a recessive disease: 22q13 deletion syndrome and metachromatic leukodystrophy.
Bisgaard AM; Kirchhoff M; Nielsen JE; Kibaek M; Lund A; Schwartz M; Christensen E
Clin Genet; 2009 Feb; 75(2):175-9. PubMed ID: 19054018
[TBL] [Abstract][Full Text] [Related]
18. Deletion 22q13.3 syndrome.
Phelan MC
Orphanet J Rare Dis; 2008 May; 3():14. PubMed ID: 18505557
[TBL] [Abstract][Full Text] [Related]
19. A de novo 7.9 Mb deletion in 22q13.2→qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings.
Chen CP; Lin SP; Chern SR; Tsai FJ; Wu PC; Lee CC; Chen YT; Chen WL; Wang W
Eur J Med Genet; 2010; 53(5):329-32. PubMed ID: 20541044
[TBL] [Abstract][Full Text] [Related]
20. Global brain dysmyelination with above-average verbal skills in 18q- syndrome with a 17 Mb terminal deletion.
Netzer C; Helmstaedter C; Ehrbrecht A; Engels H; Schwanitz G; Urbach H; Schröder R; Weber RG; Kornblum C
Acta Neurol Scand; 2006 Aug; 114(2):133-8. PubMed ID: 16867037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
